The oxidoreductase p66Shc acts as tumor suppressor in BRAFV600E‐transformed cells
Metabolic reprogramming, as exemplified by the shift from oxidative phosphorylation to glycolysis, is a common feature of transformed cells. In many tumors, altered metabolism is also reflected in increased reactive oxygen species (ROS) levels, which contribute to proliferation and survival signalin...
Main Authors: | Tobias Furlan, Sana Khalid, Anh‐Vu Nguyen, Julia Günther, Jakob Troppmair |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-06-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12199 |
Similar Items
-
Anlotinib may have a therapeutic effect on papillary craniopharyngiomas without the BRAFv600e mutation
by: Yilamujiang Ainiwan, et al.
Published: (2025-03-01) -
Rigosertib-Activated JNK1/2 Eliminate Tumor Cells through p66Shc Activation
by: Julia K. Günther, et al.
Published: (2020-05-01) -
Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib
by: Iris Car, et al.
Published: (2023-04-01) -
Regulation of Selective B Cell Autophagy by the Pro-oxidant Adaptor p66SHC
by: Anna Onnis, et al.
Published: (2020-03-01) -
p66Shc in Cardiovascular Pathology
by: Landon Haslem, et al.
Published: (2022-06-01)